A detailed history of Hemenway Trust CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Hemenway Trust CO LLC holds 1,185 shares of AMGN stock, worth $313,088. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,185
Previous 1,195 0.84%
Holding current value
$313,088
Previous $373,000 2.14%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $3,093 - $3,373
-10 Reduced 0.84%
1,185 $381,000
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $16,816 - $20,435
-64 Reduced 5.08%
1,195 $373,000
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $52,967 - $63,938
197 Added 18.55%
1,259 $357,000
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $271,553 - $306,344
1,062 New
1,062 $305,000
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $198,569 - $252,305
867 New
867 $227,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $197,771 - $235,510
-914 Closed
0 $0
Q3 2020

Oct 28, 2020

SELL
$234.65 - $260.95 $28,627 - $31,835
-122 Reduced 11.78%
914 $232,000
Q2 2020

Jul 28, 2020

BUY
$197.81 - $242.74 $204,931 - $251,478
1,036 New
1,036 $244,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $170,758 - $226,472
-937 Closed
0 $0
Q4 2019

Jan 15, 2020

BUY
$189.21 - $243.2 $177,289 - $227,878
937 New
937 $226,000
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $257,884 - $302,299
-1,547 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $36,174 - $40,776
-200 Reduced 11.45%
1,547 $294,000
Q4 2018

Jan 24, 2019

SELL
$178.4 - $208.25 $2,676 - $3,123
-15 Reduced 0.85%
1,747 $340,000
Q2 2018

Jul 30, 2018

BUY
$166.05 - $186.51 $13,284 - $14,920
80 Added 4.76%
1,762 $325,000
Q1 2018

Apr 24, 2018

BUY
$169.43 - $198.0 $284,981 - $333,036
1,682 New
1,682 $287,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hemenway Trust CO LLC Portfolio

Follow Hemenway Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.